Oxford University vaccine trial finds vaccines to be safe, tolerated, and effective. Further trials are being conducted for effectiveness in children.

Russia coronavirus tails ends today, targets next month launch

A day earlier, Russian health minister had also said they will make the coronavirus vaccine candidate available to general public before it clears the third and last phase of clinical trials

COVAXIN, developed by Hyderabad-based Bharat Biotech International Limited (BBIL), in collaboration with ICMR and NIV, Pune was the first vaccine to get regulatory approvals for clinical trials.